|
|
Volumn 25, Issue 4, 2010, Pages 419-426
|
|
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: A 26-week, open-label, prospective trial (Study ENA713B US32)
a
|
|
Author keywords
Alzheimer's disease; Cholinesterase inhibitor; Dementia; Memantine; Rivastigmine; Tolerability
|
|
Indexed keywords
MEMANTINE;
RIVASTIGMINE;
ACUTE HEART INFARCTION;
ADD ON THERAPY;
ADULT;
AGED;
AGITATION;
ALZHEIMER DISEASE;
ANXIETY;
ARTICLE;
ASTHENIA;
BRONCHITIS;
CARDIOGENIC SHOCK;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COGNITION;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DAILY LIFE ACTIVITY;
DECREASED APPETITE;
DEPRESSION;
DIARRHEA;
DIZZINESS;
DRUG CAPSULE;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG SAFETY;
DRUG TOLERABILITY;
EVENING DOSAGE;
FALLING;
FEMALE;
FUNCTIONAL ASSESSMENT;
HUMAN;
INSOMNIA;
LETHARGY;
MAJOR CLINICAL STUDY;
MALE;
MENTAL HEALTH;
MONOTHERAPY;
MORNING DOSAGE;
MULTICENTER STUDY;
NAUSEA;
OPEN STUDY;
PATIENT COMPLIANCE;
PILOT STUDY;
PNEUMONIA;
PRESCRIPTION;
PROSPECTIVE STUDY;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
SOMNOLENCE;
UNITED STATES;
URINARY TRACT INFECTION;
VOMITING;
WEIGHT REDUCTION;
ACTIVITIES OF DAILY LIVING;
ADMINISTRATION, ORAL;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
ANTIPARKINSON AGENTS;
BLOOD PRESSURE;
CAPSULES;
CHOLINESTERASE INHIBITORS;
COGNITION;
DIZZINESS;
DRUG THERAPY, COMBINATION;
EXCITATORY AMINO ACID ANTAGONISTS;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
MEMANTINE;
MIDDLE AGED;
NAUSEA;
PHENYLCARBAMATES;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
VOMITING;
|
|
EID: 77949519532
PISSN: 08856230
EISSN: 10991166
Source Type: Journal
DOI: 10.1002/gps.2355 Document Type: Article |
|
Times cited : (34)
|
|
References (15)
|
